Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading

Endocr Relat Cancer. 2008 Mar;15(1):175-81. doi: 10.1677/ERC-07-0126.

Abstract

The cytological Ki-67 expression measured on cytological samples collected by endoscopic ultrasonography-guided fine needle aspiration cytology (EUS-FNAC) may provide pre-operative indications for pancreatic endocrine tumours (PETs) management. The aim of our study was to assess reliability of Ki-67 expression measured on cytological samples obtained by EUS-FNAC in patients with PETs. Eighteen patients with PETs underwent EUS-FNAC before surgery. Ki-67 expression was measured on FNACs and on histological sections. Using a cut-off of 2%, percent agreement of Ki-67 expression on cytological and histological samples was 89% (k-statistic: 0.78, 95% confidence intervals (95% CI): 0.5, 1.0). Using cut-off values of 2 and 10%, percent agreement was 78% (k-statistic: 0.65, 95% CI: 0.3, 0.9). Ki-67 expression measured on cytological samples obtained by EUS-FNAC before surgery showed good agreement with that measured on histological samples.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy, Fine-Needle
  • Cell Differentiation
  • Endosonography
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Insulinoma / metabolism*
  • Ki-67 Antigen / metabolism*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pancreatic Neoplasms / metabolism*
  • Preoperative Care
  • Prognosis

Substances

  • Ki-67 Antigen